Reversible hair depigmentation in a Japanese female treated with pazopanib

Journal of Dermatology

Volumn 41, Issue 11, 2014, Pages 1021-1022

  Kobayashi, Eisuke ^a   Koyama, Taro ^a   Kobayashi, Kazuhiro ^a   Setsu, Nokitaka ^a   Kawashima, Makoto ^a   Kawai, Akira ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PAZOPANIB; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

ADULT; CANCER CHEMOTHERAPY; CASE REPORT; CONTINUOUS INFUSION; DEPIGMENTATION; DRUG WITHDRAWAL; FEMALE; HAIR DISEASE; HIP PROSTHESIS; HUMAN; JAPAN; LETTER; LYMPH NODE METASTASIS; MELANOCYTE; PEDICLED SKIN FLAP; REVERSIBLE HAIR DEPIGMENTATION; SOFT TISSUE SARCOMA; WIDE EXCISION; ANTAGONISTS AND INHIBITORS; BONE NEOPLASMS; CHEMICALLY INDUCED; HIP; PIGMENT DISORDER; SARCOMA;

ADULT; BONE NEOPLASMS; FEMALE; HAIR DISEASES; HIP JOINT; HUMANS; PIGMENTATION DISORDERS; PROTEIN-TYROSINE KINASES; PYRIMIDINES; SARCOMA; SULFONAMIDES;

EID: 84913588088     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.12654     Document Type: Letter

References (5)

1. Van der Graaf WT, Blay JY, Chawla SP et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012; 379: 1879-1886.
2. Tobin DJ. Human hair pigmentation-biological aspects. Int J Cosmet Sci 2008; 30: 233-257.
3. Brzezniak C, Szabo E. Images in clinical medicine. Sunitinib-associated hair depigmentation. N Engl J Med 2014; 24: e27.
4. Brazzelli V, Grasso V, Barbaccia V et al. Hair depigmentation and vitiligo-like lesions in a leukaemic paediatric patient during chemotherapy with dasatinib. Acta Derm Venereol 2012; 92: 218-219.
5. Yun SK, Song KH, Hwang SR et al. Hair graying and loss induced by imatinib mesylate. J Dermatol 2014; 41: 107-108.